RxSight, Inc. (NASDAQ: RXST) insider Eric Weinberg disposed of 449,637 derivative securities and received awards covering 334,075 on September 5, 2026. Afterward, his reported holdings stood at zero derivative securities following the disposals and 93,984 derivative securities following the awards, giving investors separate post-transaction positions.
Key Highlights
- Weinberg received awards covering 334,075 derivative securities in transactions coded A on September 5, 2026.
- His reported post-transaction balance after the awards was 93,984 derivative securities.
- The post-transaction balance following the disposals was zero derivative securities.
RxSight, Inc. (NASDAQ: RXST) recorded the disposal of 449,637 derivative securities by Eric Weinberg on September 5, 2026. The transactions left Weinberg with zero derivative securities after the disposals.
Derivative Awards and Post-Transaction Holdings
Weinberg also received awards covering 334,075 derivative securities on the same date. His reported holding following the awards was 93,984 derivative securities. RxSight’s disclosure therefore reports separate post-transaction balances for the disposals and the awards.
FAQs
Q: What did Eric Weinberg transact in RxSight derivative securities?
A: Eric Weinberg disposed of 449,637 RxSight derivative securities on September 5, 2026. He also received awards covering 334,075 derivative securities on that date.
Q: What was Weinberg’s RxSight holding after the transactions?
A: Weinberg’s post-transaction RxSight holding was zero derivative securities following the disposals. His reported holding following the awards was 93,984 derivative securities.
Q: What is the key detail from this filing?
A: RxSight, Inc. (NASDA
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.